Search results
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 12 hours agoPfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 7 hours agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 1 day agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Pfizer and Levi Strauss Face Challenges from Conservative Shareholders Over Support of Divisive...
National Center for Public Policy Research· 11 hours agoWashington, D.C. – At this week’s Pfizer and Levi Strauss annual shareholder meetings, shareholder...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 2 days agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 24 hours agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 1 day agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer (PFE) Rises Higher Than Market: Key Facts
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) closed at $26.26 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily gain of 0.87%....
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 7 days agoIf you had bought $1,000 worth of Pfizer (NYSE: PFE) shares five years ago, how much would that be...